Abstract:One of the challenging problems in the etiology of diseases is to explore the relationships between initiation and progression of diseases and abnormalities in local regions of metabolic pathways. To gain insight into such relationships, we applied the "k-clique" subpathway identification method to all disease-related gene sets. For each disease, the disease risk regions of metabolic pathways were then identified and considered as subpathways associated with the disease. We finally built a disease-metabolic subpathway network (DMSPN). Through analyses based on network biology, we found that a few subpathways, such as that of cytochrome P450, were highly connected with many diseases, and most belonged to fundamental metabolisms, suggesting that abnormalities of fundamental metabolic processes tend to cause more types of diseases. According to the categories of diseases and subpathways, we tested the clustering phenomenon of diseases and metabolic subpathways in the DMSPN. The results showed that both disease nodes and subpathway nodes displayed slight clustering phenomenon. We also tested correlations between network topology and genes within disease-related metabolic subpathways, and found that within a disease-related subpathway in the DMSPN, the ratio of disease genes and the ratio of tissue-specific genes significantly increased as the number of diseases caused by the subpathway increased. Surprisingly, the ratio of essential genes significantly decreased and the ratio of housekeeping genes remained relatively unchanged. Furthermore, the coexpression levels between disease genes and other types of genes were calculated for each subpathway in the DMSPN. The results indicated that those genes intensely influenced by disease genes, including essential genes and tissue-specific genes, might be significantly associated with the disease diversity of subpathways, suggesting that different kinds of genes within a disease-related subpathway may play significantly differential roles on the diversity of diseases caused by the corresponding subpathway.

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.

Subpathway-CorSP: Identification of Metabolic Subpathways Via Integrating Expression Correlations and Topological Features Between Metabolites and Genes of Interest Within Pathways

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.

Autonomous Multimodal Metabolomics Data Integration for Comprehensive Pathway Analysis and Systems Biology

A Network-Based Pathway-Expanding Approach for Pathway Analysis

MPINet: Metabolite Pathway Identification Via Coupling of Global Metabolite Network Structure and Metabolomic Profile.

Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case

The implications of relationships between human diseases and metabolic subpathways

Identification of Common and Subtype-Specific Mutated Sub-Pathways for a Cancer.

Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme

psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data

Ce-Subpathway: Identification Of Cerna-Mediated Subpathways Via Joint Power Of Cernas And Pathway Topologies

Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma

PathDriver: Cancer Driver Genes Identification Based on the Metabolic Pathway

Subpathway Analysis Based On Signaling-Pathway Impact Analysis Of Signaling Pathway

A network-based pathway-extending approach using DNA methylation and gene expression data to identify altered pathways

A Network-Based Strategy from the Global Perspective for Identification of Risk Pathways in Complex Diseases

LncSubpathway: a Novel Approach for Identifying Dysfunctional Subpathways Associated with Risk Lncrnas by Integrating Lncrna and Mrna Expression Profiles and Pathway Topologies